Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions

Background Natural killer (NK) cells play a crucial role in tumor immunosurveillance through their cytotoxic effector functions and their capacity to interact with other immune cells to build a coordinated antitumor immune response. Emerging data reveal NK cell dysfunction within the tumor microenvi...

Full description

Saved in:
Bibliographic Details
Main Authors: Diane Damotte, Laurence Zitvogel, Marco Alifano, Marie-Caroline Dieu-Nosjean, Gabriela Bindea, Jeremy Goc, Jules Russick, Pierre-Emmanuel Joubert, Mélanie Gillard-Bocquet, Carine Torset, Maxime Meylan, Florent Petitprez, Marie-Agnes Dragon-Durey, Solenne Marmier, Aditi Varthaman, Nathalie Josseaume, Claire Germain, Pierre Validire, Ludovic Fournel, Audrey Lupo, Isabelle Cremer
Format: Article
Language:English
Published: BMJ Publishing Group 2020-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001054.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850196819791839232
author Diane Damotte
Laurence Zitvogel
Marco Alifano
Marie-Caroline Dieu-Nosjean
Gabriela Bindea
Jeremy Goc
Jules Russick
Pierre-Emmanuel Joubert
Mélanie Gillard-Bocquet
Carine Torset
Maxime Meylan
Florent Petitprez
Marie-Agnes Dragon-Durey
Solenne Marmier
Aditi Varthaman
Nathalie Josseaume
Claire Germain
Pierre Validire
Ludovic Fournel
Audrey Lupo
Isabelle Cremer
author_facet Diane Damotte
Laurence Zitvogel
Marco Alifano
Marie-Caroline Dieu-Nosjean
Gabriela Bindea
Jeremy Goc
Jules Russick
Pierre-Emmanuel Joubert
Mélanie Gillard-Bocquet
Carine Torset
Maxime Meylan
Florent Petitprez
Marie-Agnes Dragon-Durey
Solenne Marmier
Aditi Varthaman
Nathalie Josseaume
Claire Germain
Pierre Validire
Ludovic Fournel
Audrey Lupo
Isabelle Cremer
author_sort Diane Damotte
collection DOAJ
description Background Natural killer (NK) cells play a crucial role in tumor immunosurveillance through their cytotoxic effector functions and their capacity to interact with other immune cells to build a coordinated antitumor immune response. Emerging data reveal NK cell dysfunction within the tumor microenvironment (TME) through checkpoint inhibitory molecules associated with a regulatory phenotype.Objective We aimed at analyzing the gene expression profile of intratumoral NK cells compared with non-tumorous NK cells, and to characterize their inhibitory function in the TME.Methods NK cells were sorted from human lung tumor tissue and compared with non- tumoral distant lungs.Results In the current study, we identify a unique gene signature of NK cell dysfunction in human non-small cell lung carcinoma (NSCLC). First, transcriptomic analysis reveals significant changes related to migratory pattern with a downregulation of sphingosine-1-phosphate receptor 1 (S1PR1) and CX3C chemokine receptor 1 (CX3CR1) and overexpression of C-X-C chemokine receptor type 5 (CXCR5) and C-X-C chemokine receptor type 6 (CXCR6). Second, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and killer cell lectin like receptor (KLRC1) inhibitory molecules were increased in intratumoral NK cells, and CTLA-4 blockade could partially restore MHC class II level on dendritic cell (DC) that was impaired during the DCs/NK cell cross talk. Finally, NK cell density impacts the positive prognostic value of CD8+ T cells in NSCLC.Conclusions These findings demonstrate novel molecular cues associated with NK cell inhibitory functions in NSCLC.
format Article
id doaj-art-66cfd0aa9b7a4ab3ad675fae3785d405
institution OA Journals
issn 2051-1426
language English
publishDate 2020-10-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-66cfd0aa9b7a4ab3ad675fae3785d4052025-08-20T02:13:20ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-10-018210.1136/jitc-2020-001054Natural killer cells in the human lung tumor microenvironment display immune inhibitory functionsDiane Damotte0Laurence Zitvogel1Marco Alifano2Marie-Caroline Dieu-Nosjean3Gabriela Bindea4Jeremy Goc5Jules Russick6Pierre-Emmanuel Joubert7Mélanie Gillard-Bocquet8Carine Torset9Maxime Meylan10Florent Petitprez11Marie-Agnes Dragon-Durey12Solenne Marmier13Aditi Varthaman14Nathalie Josseaume15Claire Germain16Pierre Validire17Ludovic Fournel18Audrey Lupo19Isabelle Cremer201 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France8 Universite Paris Saclay, Le Kremlin-Bicêtre, FranceDepartment of Thoracic Surgery, Hospital Cochin Assistance Publique Hopitaux de Paris, APHP, Paris, Île-de-France, FranceSorbonne University, UMRS 1135, INSERM U1135, Centre d`Immunologie et des Maladies Infectieuses (Cimi-Paris), INSERM, Paris, Île-de-France, FranceAff142 grid.10992.330000000121880914INSERM, Université Pierre et Marie CurieUniversité Paris Descartes Paris FranceAff8 grid.417925.cINSERM, U1138, Centre de Recherche des Cordeliers Paris France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, FranceEquipe inflammation, complément et cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris-Cité, Paris, France2 Programme Cartes d`Identité des Tumeurs, Ligue Nationale Contre le Cancer, Paris, France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France5 Department of Pathology, Institut Mutualiste Montsouris, Paris, France6 Departments of Pathology and Thoracic Surgery, Hospital Cochin Assistance Publique Hopitaux de Paris, F-75014, Paris, France1 Centre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, FranceINSERM U1138, Centre de Recherche des Cordeliers, Université de Paris, Sorbonne Université, 75006 Paris, FranceBackground Natural killer (NK) cells play a crucial role in tumor immunosurveillance through their cytotoxic effector functions and their capacity to interact with other immune cells to build a coordinated antitumor immune response. Emerging data reveal NK cell dysfunction within the tumor microenvironment (TME) through checkpoint inhibitory molecules associated with a regulatory phenotype.Objective We aimed at analyzing the gene expression profile of intratumoral NK cells compared with non-tumorous NK cells, and to characterize their inhibitory function in the TME.Methods NK cells were sorted from human lung tumor tissue and compared with non- tumoral distant lungs.Results In the current study, we identify a unique gene signature of NK cell dysfunction in human non-small cell lung carcinoma (NSCLC). First, transcriptomic analysis reveals significant changes related to migratory pattern with a downregulation of sphingosine-1-phosphate receptor 1 (S1PR1) and CX3C chemokine receptor 1 (CX3CR1) and overexpression of C-X-C chemokine receptor type 5 (CXCR5) and C-X-C chemokine receptor type 6 (CXCR6). Second, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and killer cell lectin like receptor (KLRC1) inhibitory molecules were increased in intratumoral NK cells, and CTLA-4 blockade could partially restore MHC class II level on dendritic cell (DC) that was impaired during the DCs/NK cell cross talk. Finally, NK cell density impacts the positive prognostic value of CD8+ T cells in NSCLC.Conclusions These findings demonstrate novel molecular cues associated with NK cell inhibitory functions in NSCLC.https://jitc.bmj.com/content/8/2/e001054.full
spellingShingle Diane Damotte
Laurence Zitvogel
Marco Alifano
Marie-Caroline Dieu-Nosjean
Gabriela Bindea
Jeremy Goc
Jules Russick
Pierre-Emmanuel Joubert
Mélanie Gillard-Bocquet
Carine Torset
Maxime Meylan
Florent Petitprez
Marie-Agnes Dragon-Durey
Solenne Marmier
Aditi Varthaman
Nathalie Josseaume
Claire Germain
Pierre Validire
Ludovic Fournel
Audrey Lupo
Isabelle Cremer
Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
Journal for ImmunoTherapy of Cancer
title Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
title_full Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
title_fullStr Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
title_full_unstemmed Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
title_short Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
title_sort natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
url https://jitc.bmj.com/content/8/2/e001054.full
work_keys_str_mv AT dianedamotte naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT laurencezitvogel naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT marcoalifano naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT mariecarolinedieunosjean naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT gabrielabindea naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT jeremygoc naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT julesrussick naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT pierreemmanueljoubert naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT melaniegillardbocquet naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT carinetorset naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT maximemeylan naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT florentpetitprez naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT marieagnesdragondurey naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT solennemarmier naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT aditivarthaman naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT nathaliejosseaume naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT clairegermain naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT pierrevalidire naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT ludovicfournel naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT audreylupo naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions
AT isabellecremer naturalkillercellsinthehumanlungtumormicroenvironmentdisplayimmuneinhibitoryfunctions